Spiriva respimat and Acyclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Spiriva respimat (tiotropium bromide) and Acyclovir (acyclovir). Common drug interactions include migraine among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Spiriva respimat and Acyclovir. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Spiriva respimat?

Spiriva respimat has active ingredients of tiotropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 9,788 Spiriva respimat users. Check the latest studies of Spiriva respimat.

What is Acyclovir?

Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.



On Jul, 15, 2026

35 people who take Spiriva respimat and Acyclovir together, and have interactions are studied.

Spiriva respimat and Acyclovir drug interactions.

What are the common drug interactions of Spiriva Respimat and Acyclovir, by gender? *:

female:

  1. Migraine (headache)
  2. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  3. Neuropathy peripheral (surface nerve damage)
  4. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Weight gain poor
  7. Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness)
  8. Hypertension (high blood pressure)
  9. Nervousness
  10. Nightmare (unpleasant dream)

male:

  1. Fatigue (feeling of tiredness)
  2. Dyspnoea (difficult or laboured respiration)
  3. Dysarthria (speech disorder)
  4. Dyspnoea exertional (breathlessness or shortness of breath)
  5. Eyelid ptosis (falling of the upper or lower eyelid)
  6. Fall
  7. Flushing (the warm, red condition of human skin)
  8. Gait disturbance
  9. Middle ear effusion (fluid in middle ear)
  10. Muscle spasticity (tight or stiff muscles and an inability to control those muscles)

What are the common drug interactions of Spiriva Respimat and Acyclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness)
  2. Drug ineffective
  3. Dyspnoea (difficult or laboured respiration)
  4. Fatigue (feeling of tiredness)
  5. Feeling hot
  6. Headache (pain in head)
  7. Hypertension (high blood pressure)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Memory impairment
  10. Nervousness

50-59:

  1. Abdominal tenderness
  2. Acute respiratory failure
  3. Adverse drug reaction
  4. Chest discomfort
  5. Cough
  6. Dehydration (dryness resulting from the removal of water)
  7. Diarrhoea
  8. Dry mouth
  9. Dyspnoea (difficult or laboured respiration)
  10. Injection site bruising

60+:

  1. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  2. Fatigue (feeling of tiredness)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Anxiety
  5. Arthralgia (joint pain)
  6. Blood pressure increased
  7. Diastolic dysfunction
  8. Dysarthria (speech disorder)
  9. Dyspnoea exertional (breathlessness or shortness of breath)
  10. Eyelid ptosis (falling of the upper or lower eyelid)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 9 people, 25.71%
  2. Multiple Myeloma (cancer of the plasma cells): 8 people, 22.86%
  3. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 11.43%
  4. Pain: 3 people, 8.57%
  5. Asthma: 3 people, 8.57%
  6. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 5.71%
  7. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 5.71%
  8. Nausea (feeling of having an urge to vomit): 2 people, 5.71%
  9. Insomnia (sleeplessness): 2 people, 5.71%
  10. Ill-Defined Disorder: 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Spiriva respimat and Acyclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Spiriva respimat and Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Spiriva respimat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Spiriva respimat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on tiotropium bromide and acyclovir (the active ingredients of Spiriva respimat and Acyclovir, respectively), and Spiriva respimat and Acyclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: